Elevated serum FABP4 concentrations are associated with obesity, insulin resistance, hypertension, inflammation, atherosclerosis, and metabolic syndrome, thus positioning FABP4 as a potential independent biomarker for metabolic and cardiovascular diseases [4]. Here, FABP4 is linked to metabolic syndrome.